Regab 75 mg (Pregabalin) Capsules

Introduction:

Regab 75 mg, manufactured by Beacon Pharmaceuticals Ltd and supplied by Orio Pharma, is a medication used to treat a variety of conditions, including neuropathic pain, fibromyalgia, and partial seizures. Containing Pregabalin, Regab 75 mg is particularly effective in managing chronic pain conditions related to nerve damage. Additionally, it is used as an adjunctive therapy for epilepsy and for treating widespread pain associated with fibromyalgia. This medication offers a reliable solution for patients seeking relief from chronic pain and seizure disorders, significantly improving their quality of life.

Manufacturing Excellence of Beacon Pharmaceuticals Ltd.:

Beacon Pharmaceuticals Ltd. is committed to producing high-quality pharmaceutical products that meet stringent international standards. The development of Regab 75 mg reflects Beacon’s dedication to advancing treatments for pain and neurological disorders through innovative research, rigorous quality control, and adherence to best manufacturing practices. Their focus on safety and efficacy ensures that Regab 75 mg is a reliable and effective option for managing neuropathic pain, seizures, and fibromyalgia.

Mechanism of Action:

Regab 75 mg contains Pregabalin, a medication that works by binding to the alpha-2-delta subunit of voltage-gated calcium channels in the central nervous system. This binding reduces the release of several neurotransmitters, including glutamate, norepinephrine, and substance P, which are involved in the transmission of pain signals and seizure activity. By modulating these neurotransmitters, Pregabalin helps to decrease the intensity of neuropathic pain, reduce the frequency of seizures, and alleviate the widespread pain associated with fibromyalgia.

Clinical Applications:

Regab 75 mg is indicated for the treatment of:

• Neuropathic Pain: Regab 75 mg is used to treat neuropathic pain associated with diabetic peripheral neuropathy, postherpetic neuralgia, and spinal cord injury. It is also effective in managing central neuropathic pain.
• Fibromyalgia: Regab 75 mg provides relief from the widespread pain and tenderness associated with fibromyalgia, improving physical function and overall quality of life for patients.
• Partial-Onset Seizures: Regab 75 mg is used as an adjunctive therapy for adults with partial-onset seizures, helping to reduce the frequency of seizures in patients with epilepsy.

Clinical studies have demonstrated that Pregabalin is highly effective in managing these conditions, providing significant pain relief and improving seizure control in patients with epilepsy.

Dosage and Administration:

The recommended dosage of Regab 75 mg varies depending on the condition being treated. Typically, the dosage starts at 75 mg taken twice daily, with adjustments made based on the patient’s response and tolerability. The capsules should be swallowed whole with water, and it is important for patients to follow their healthcare provider’s instructions carefully. Dose adjustments may be necessary for patients with renal impairment, and the medication should not be discontinued abruptly to avoid withdrawal symptoms.

Benefits of Regab 75 mg:

• Effective Neuropathic Pain Relief: Regab 75 mg provides significant relief from the chronic pain associated with neuropathy, improving the quality of life for patients.
• Seizure Control: Regab 75 mg is effective as an adjunctive therapy for partial-onset seizures, helping to reduce seizure frequency in patients with epilepsy.
• Fibromyalgia Management: Regab 75 mg offers relief from the widespread pain and tenderness of fibromyalgia, improving physical function and daily living activities.
• Well-Tolerated: Regab 75 mg is generally well-tolerated, with a favorable safety profile when used according to the prescribed dosage and duration.

Supplier: Orio Pharma

Orio Pharma ensures that Regab 75 mg is readily available to healthcare providers and patients, offering reliable access to this essential medication for pain and seizure management. Their commitment to efficient supply and distribution supports effective treatment of neuropathic pain, fibromyalgia, and seizures, helping to improve patient outcomes.

Conclusion:

Regab 75 mg (Pregabalin) by Beacon Pharmaceuticals Ltd, supplied by Orio Pharma, represents a trusted and effective solution for managing neuropathic pain, fibromyalgia, and partial seizures. This medication offers significant relief from chronic pain and improves seizure control, enhancing the quality of life for patients. By incorporating Regab 75 mg into their treatment plans, healthcare providers can offer patients a reliable and effective strategy for managing these challenging conditions, ultimately leading to better health outcomes and long-term symptom relief.